Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Oncotarget
Michael T BarrettBarbara A Pockaj

Abstract

We used DNA content flow cytometry followed by oligonucleotide array based comparative genomic hybridization to survey the genomes of 326 tumors, including 41 untreated surgically resected triple negative breast cancers (TNBC). A high level (log2ratio ≥ 1) 9p24 amplicon was found in TNBC (12/41), glioblastomas (2/44), and colon carcinomas (2/68). The shortest region of overlap for the amplicon targets 9p24.1 and includes the loci for PD-L1, PD-L2, and JAK2 (PDJ amplicon). In contrast this amplicon was absent in ER+ (0/8) and HER2+ (0/15) breast tumors, and in pancreatic ductal adenocarcinomas (0/150). The PDJ amplicon in TNBCs was correlated with clinical outcomes in group comparisons by two-sample t-tests for continuous variables and chi-squared tests for categorical variables. TNBC patients with the PDJ amplicon had a worse outcome with worse disease-free and overall survival. Quantitative RT-PCR confirmed that the PDJ amplicon in TNBC is associated with elevated expression of JAK2 and of the PD-1 ligands. These initial findings demonstrate that the PDJ amplicon is enriched in TNBC, targets signaling pathways that activate the PD-1 mediated immune checkpoint, and identifies patients with a poor prognosis.

References

Jan 1, 1994·Methods in Cell Biology·P S Rabinovitch
May 13, 1999·Nature Genetics·M T BarrettB J Reid
Nov 28, 2001·The American Journal of Gastroenterology·P S RabinovitchB J Reid
Mar 28, 2006·Nature Genetics·Carlo C MaleyBrian J Reid
Apr 7, 2006·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Doron LipsonZohar Yakhini
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qiang GaoJia Fan
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Srdan Verstovsek
Feb 2, 2011·Nature Reviews. Drug Discovery·Alfonso Quintás-CardamaSrdan Verstovsek
Jun 3, 2011·The Journal of Clinical Investigation·Lauren L C MarottaKornelia Polyak
Jul 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christian RuizMichael T Barrett
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Dec 12, 2012·PloS One·Tara HolleyMichael T Barrett
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Oct 12, 2013·The Journal of Pathology·Brian D Lehmann, Jennifer A Pietenpol
Feb 4, 2014·Genome Medicine·Lisa EversMichael T Barrett
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Mar 13, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yansheng HaoMargaret A Shipp
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janis M TaubeRobert A Anders
Apr 26, 2014·Cancer Immunology Research·Elizabeth A MittendorfGheath Alatrash
Jun 28, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Antoni Ribas, Paul C Tumeh
Jul 9, 2014·Nature Reviews. Clinical Oncology·Ignacio MeleroHåkan Mellstedt
Jul 12, 2014·BMC Genomics·Ewa PrzybytkowskiMark Basik
Jul 22, 2014·Molecular Oncology·Salvatore PiscuoglioJorge S Reis-Filho
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi

❮ Previous
Next ❯

Citations

Nov 20, 2016·PloS One·Semir VranicZoran Gatalica
Jul 20, 2017·British Journal of Cancer·Michael T BarrettDaniel D Von Hoff
Jul 29, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Meixuan ChenKaren S Anderson
Feb 10, 2018·Current Medicinal Chemistry·Andrea NicoliniAngelo Carpi
May 3, 2019·International Journal of Cancer. Journal International Du Cancer·Alanna MaguireLisa M Rimsza
Jan 24, 2020·Scientific Reports·José Luis Granados-SolerIngo Nolte
Feb 12, 2020·Applied Immunohistochemistry & Molecular Morphology : AIMM·Jérémy PérottetArnaud Uguen
Jun 2, 2016·Oncotarget·Lian ZhaoShourong Shen
Sep 22, 2016·Molecular & Cellular Oncology·Luis J Schwarz, Justin M Balko
Apr 7, 2017·Histopathology·Karen ZwaenepoelPatrick Pauwels
Dec 14, 2018·Oncoimmunology·Troy A McEachronJohn D Carpten
Dec 24, 2018·Therapeutic Advances in Medical Oncology·Federico Pio FabrizioLucia Anna Muscarella
Dec 21, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·May P ChanPaul W Harms
Nov 3, 2016·Nature Reviews. Clinical Oncology·Aaron GoodmanRazelle Kurzrock
May 4, 2016·Immunotherapy·Ryan GentzlerOsama E Rahma
Apr 15, 2016·Journal of the National Cancer Institute·Nathan SimonDavid FitzGerald
Jul 29, 2016·Oncoimmunology·Andreas H ScheelJürgen Wolf
Oct 11, 2019·Journal of breast cancer·Maryam NakhjavaniAmanda R Townsend
Dec 11, 2019·Journal of Clinical Medicine·Barbara Seliger
Jun 5, 2020·Scientific Reports·Yujie FuGavin P Dunn
Dec 13, 2017·Expert Opinion on Investigational Drugs·Andres ChangPamela B Allen
Oct 12, 2018·NPJ Precision Oncology·James M BogenbergerMitesh J Borad
Jul 17, 2016·Medical Oncology·Semra PaydasGulfiliz Gonlusen
Jul 13, 2018·Breast Cancer Research : BCR·Michael T BarrettBarbara A Pockaj
Apr 19, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sounak GuptaVictor E Reuter
Jul 22, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elizabeth D ThompsonAshley Cimino-Mathews
Jul 25, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Jérémy PérottetArnaud Uguen

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
biopsies
surgical resection
Feature Extraction
PCR

Software Mentioned

Agilent Feature Extraction
MultiCycle
GraphPad Prism

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
E A te VeldeP J van Diest
International Journal of Clinical and Experimental Pathology
Shir-Hwa UengChuen Hsueh
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Ching-Yao YangPan-Chyr Yang
© 2021 Meta ULC. All rights reserved